Treatment of asymptomatic catecholaminergic polymorphic ventricular tachycardia.

about

Treatment of asymptomatic catecholaminergic polymorphic ventricular tachycardia.

Item

http://www.wikidata.org/entity/Q38014115

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Treatment of asymptomatic catecholaminergic polymorphic ventricular tachycardia.

@en

type

Item

label

Treatment of asymptomatic catecholaminergic polymorphic ventricular tachycardia.

@en

prefLabel

Treatment of asymptomatic catecholaminergic polymorphic ventricular tachycardia.

@en

P1476

Treatment of asymptomatic catecholaminergic polymorphic ventricular tachycardia.

@en

P2093

Allan C Skanes

http://www.w3.org/2001/XMLSchema#string

Andrew D Krahn

http://www.w3.org/2001/XMLSchema#string

George J Klein

http://www.w3.org/2001/XMLSchema#string

Lorne J Gula

http://www.w3.org/2001/XMLSchema#string

Manoj N Obeyesekere

http://www.w3.org/2001/XMLSchema#string

Peter Leong-Sit

http://www.w3.org/2001/XMLSchema#string

Raymond W Sy

http://www.w3.org/2001/XMLSchema#string

Raymond Yee

http://www.w3.org/2001/XMLSchema#string

P2860

Expanding spectrum of human RYR2-related disease: new electrocardiographic, structural, and genetic features

A cardiac arrhythmia syndrome caused by loss of ankyrin-B function

Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans

Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death

Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia

Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia

A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel

The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading fram

Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

P304

439-450

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FCA.12.12

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22642633

http://www.w3.org/2001/XMLSchema#string

P921

catecholaminergic polymorphic ventricular tachycardia